Cervical Adenosquamous Cell Carcinoma Active Not Recruiting Phase 1 Trials for Atezolizumab (DB11595)

Also known as: Cervical Adenosquamous Carcinoma / Adenosquamous carcinoma of the cervix / Adenosquamous carcinoma of cervix (disorder)

IndicationStatusPhase
DBCOND0034091 (Cervical Adenosquamous Cell Carcinoma)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03738228Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical CancerTreatment